In a study published in Cell Reports Physical Science on Nov. 25, a research team reported the development of an innovative ...
Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced a licensing agreement for its CHO Edge System with RevOpsis Therapeutics ("RevOpsis"), a nex ...
Recent studies reveal that individual cells possess the ability to learn, refuting the idea that complex learning behaviors ...